nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CHRM3—nephrolithiasis	0.731	1	CbGaD
Ziprasidone—CHRM3—ureter—nephrolithiasis	0.0086	0.231	CbGeAlD
Ziprasidone—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00285	0.0276	CcSEcCtD
Ziprasidone—Aripiprazole—CHRM3—nephrolithiasis	0.00232	0.65	CrCbGaD
Ziprasidone—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00218	0.0211	CcSEcCtD
Ziprasidone—CYP1A2—urine—nephrolithiasis	0.00212	0.0569	CbGeAlD
Ziprasidone—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.00208	0.0202	CcSEcCtD
Ziprasidone—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.00191	0.0185	CcSEcCtD
Ziprasidone—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00185	0.0179	CcSEcCtD
Ziprasidone—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00182	0.0177	CcSEcCtD
Ziprasidone—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.0017	0.0165	CcSEcCtD
Ziprasidone—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00169	0.0164	CcSEcCtD
Ziprasidone—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00167	0.0162	CcSEcCtD
Ziprasidone—HTR2A—urine—nephrolithiasis	0.00166	0.0445	CbGeAlD
Ziprasidone—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00166	0.0161	CcSEcCtD
Ziprasidone—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00161	0.0157	CcSEcCtD
Ziprasidone—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00161	0.0157	CcSEcCtD
Ziprasidone—Gout—Hydrochlorothiazide—nephrolithiasis	0.0016	0.0156	CcSEcCtD
Ziprasidone—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00158	0.0154	CcSEcCtD
Ziprasidone—CYP3A4—urine—nephrolithiasis	0.00154	0.0412	CbGeAlD
Ziprasidone—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00153	0.0148	CcSEcCtD
Ziprasidone—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00153	0.0148	CcSEcCtD
Ziprasidone—CYP2D6—urine—nephrolithiasis	0.00151	0.0405	CbGeAlD
Ziprasidone—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00147	0.0143	CcSEcCtD
Ziprasidone—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00141	0.0137	CcSEcCtD
Ziprasidone—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00135	0.0131	CcSEcCtD
Ziprasidone—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00135	0.0131	CcSEcCtD
Ziprasidone—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.00133	0.0357	CbGeAlD
Ziprasidone—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00125	0.0121	CcSEcCtD
Ziprasidone—Clozapine—CHRM3—nephrolithiasis	0.00125	0.35	CrCbGaD
Ziprasidone—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00124	0.012	CcSEcCtD
Ziprasidone—Injury—Hydrochlorothiazide—nephrolithiasis	0.00118	0.0115	CcSEcCtD
Ziprasidone—H1F0—nephron tubule—nephrolithiasis	0.00116	0.0311	CbGeAlD
Ziprasidone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00116	0.0112	CcSEcCtD
Ziprasidone—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00115	0.0112	CcSEcCtD
Ziprasidone—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00115	0.0111	CcSEcCtD
Ziprasidone—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00115	0.0111	CcSEcCtD
Ziprasidone—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00114	0.0111	CcSEcCtD
Ziprasidone—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00114	0.0111	CcSEcCtD
Ziprasidone—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00114	0.0305	CbGeAlD
Ziprasidone—ADRA1B—renal system—nephrolithiasis	0.00112	0.03	CbGeAlD
Ziprasidone—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00109	0.0106	CcSEcCtD
Ziprasidone—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00109	0.0105	CcSEcCtD
Ziprasidone—ADRA1B—kidney—nephrolithiasis	0.00108	0.029	CbGeAlD
Ziprasidone—H1F0—renal system—nephrolithiasis	0.00106	0.0283	CbGeAlD
Ziprasidone—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00105	0.0102	CcSEcCtD
Ziprasidone—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00992	CcSEcCtD
Ziprasidone—H1F0—kidney—nephrolithiasis	0.00102	0.0273	CbGeAlD
Ziprasidone—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00988	CcSEcCtD
Ziprasidone—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.001	0.00974	CcSEcCtD
Ziprasidone—H1F0—cortex of kidney—nephrolithiasis	0.000994	0.0266	CbGeAlD
Ziprasidone—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.000993	0.00964	CcSEcCtD
Ziprasidone—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.000989	0.0096	CcSEcCtD
Ziprasidone—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.000982	0.00953	CcSEcCtD
Ziprasidone—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.000979	0.0095	CcSEcCtD
Ziprasidone—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.000962	0.00934	CcSEcCtD
Ziprasidone—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00094	0.00912	CcSEcCtD
Ziprasidone—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00094	0.00912	CcSEcCtD
Ziprasidone—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.000915	0.00888	CcSEcCtD
Ziprasidone—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000879	0.00853	CcSEcCtD
Ziprasidone—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.000873	0.00847	CcSEcCtD
Ziprasidone—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.000865	0.0084	CcSEcCtD
Ziprasidone—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.000858	0.00832	CcSEcCtD
Ziprasidone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.000855	0.0083	CcSEcCtD
Ziprasidone—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000848	0.00822	CcSEcCtD
Ziprasidone—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.000843	0.00818	CcSEcCtD
Ziprasidone—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.000824	0.00799	CcSEcCtD
Ziprasidone—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.000821	0.00797	CcSEcCtD
Ziprasidone—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.000817	0.00792	CcSEcCtD
Ziprasidone—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.000814	0.0079	CcSEcCtD
Ziprasidone—Sweating—Hydrochlorothiazide—nephrolithiasis	0.000803	0.00779	CcSEcCtD
Ziprasidone—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.000799	0.00775	CcSEcCtD
Ziprasidone—HTR1D—kidney—nephrolithiasis	0.00079	0.0212	CbGeAlD
Ziprasidone—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00079	0.00767	CcSEcCtD
Ziprasidone—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.000766	0.00743	CcSEcCtD
Ziprasidone—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.000754	0.00732	CcSEcCtD
Ziprasidone—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.000752	0.0073	CcSEcCtD
Ziprasidone—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.000748	0.00726	CcSEcCtD
Ziprasidone—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.000747	0.00724	CcSEcCtD
Ziprasidone—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.000741	0.00719	CcSEcCtD
Ziprasidone—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.000725	0.00703	CcSEcCtD
Ziprasidone—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000701	0.0068	CcSEcCtD
Ziprasidone—CHRM3—renal system—nephrolithiasis	0.000684	0.0183	CbGeAlD
Ziprasidone—HTR1A—renal system—nephrolithiasis	0.000681	0.0183	CbGeAlD
Ziprasidone—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000672	0.00652	CcSEcCtD
Ziprasidone—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.000665	0.00645	CcSEcCtD
Ziprasidone—CHRM3—kidney—nephrolithiasis	0.000661	0.0177	CbGeAlD
Ziprasidone—ADRA2C—nephron tubule—nephrolithiasis	0.000658	0.0176	CbGeAlD
Ziprasidone—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000655	0.00635	CcSEcCtD
Ziprasidone—HTR7—renal system—nephrolithiasis	0.000651	0.0175	CbGeAlD
Ziprasidone—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000645	0.00626	CcSEcCtD
Ziprasidone—Back pain—Hydrochlorothiazide—nephrolithiasis	0.000633	0.00615	CcSEcCtD
Ziprasidone—HTR7—kidney—nephrolithiasis	0.00063	0.0169	CbGeAlD
Ziprasidone—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000629	0.00611	CcSEcCtD
Ziprasidone—ADRA1A—renal system—nephrolithiasis	0.000628	0.0168	CbGeAlD
Ziprasidone—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000617	0.00599	CcSEcCtD
Ziprasidone—Tremor—Hydrochlorothiazide—nephrolithiasis	0.000613	0.00595	CcSEcCtD
Ziprasidone—KCNH2—renal system—nephrolithiasis	0.000607	0.0163	CbGeAlD
Ziprasidone—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.000605	0.00587	CcSEcCtD
Ziprasidone—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000602	0.00584	CcSEcCtD
Ziprasidone—ADRA2C—renal system—nephrolithiasis	0.000599	0.016	CbGeAlD
Ziprasidone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.000598	0.00581	CcSEcCtD
Ziprasidone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000588	0.00571	CcSEcCtD
Ziprasidone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000587	0.0057	CcSEcCtD
Ziprasidone—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000586	0.00569	CcSEcCtD
Ziprasidone—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000579	0.00561	CcSEcCtD
Ziprasidone—ADRA2C—kidney—nephrolithiasis	0.000579	0.0155	CbGeAlD
Ziprasidone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000575	0.00558	CcSEcCtD
Ziprasidone—Cough—Hydrochlorothiazide—nephrolithiasis	0.000571	0.00554	CcSEcCtD
Ziprasidone—ADRA2C—cortex of kidney—nephrolithiasis	0.000564	0.0151	CbGeAlD
Ziprasidone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000557	0.00541	CcSEcCtD
Ziprasidone—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000557	0.00541	CcSEcCtD
Ziprasidone—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000557	0.00541	CcSEcCtD
Ziprasidone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000556	0.00539	CcSEcCtD
Ziprasidone—CYP3A5—nephron tubule—nephrolithiasis	0.000551	0.0148	CbGeAlD
Ziprasidone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000545	0.00529	CcSEcCtD
Ziprasidone—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000539	0.00523	CcSEcCtD
Ziprasidone—Shock—Hydrochlorothiazide—nephrolithiasis	0.000526	0.0051	CcSEcCtD
Ziprasidone—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000523	0.00508	CcSEcCtD
Ziprasidone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000522	0.00506	CcSEcCtD
Ziprasidone—CYP1A2—renal system—nephrolithiasis	0.000519	0.0139	CbGeAlD
Ziprasidone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000517	0.00501	CcSEcCtD
Ziprasidone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000509	0.00494	CcSEcCtD
Ziprasidone—CYP3A5—renal system—nephrolithiasis	0.000501	0.0134	CbGeAlD
Ziprasidone—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000499	0.00484	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000487	0.00472	CcSEcCtD
Ziprasidone—CYP3A5—kidney—nephrolithiasis	0.000484	0.013	CbGeAlD
Ziprasidone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000483	0.00469	CcSEcCtD
Ziprasidone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00048	0.00466	CcSEcCtD
Ziprasidone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000476	0.00462	CcSEcCtD
Ziprasidone—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000475	0.00461	CcSEcCtD
Ziprasidone—CYP3A5—cortex of kidney—nephrolithiasis	0.000472	0.0126	CbGeAlD
Ziprasidone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00047	0.00456	CcSEcCtD
Ziprasidone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000465	0.00451	CcSEcCtD
Ziprasidone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000461	0.00447	CcSEcCtD
Ziprasidone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000457	0.00443	CcSEcCtD
Ziprasidone—ADRA2A—cortex of kidney—nephrolithiasis	0.00045	0.0121	CbGeAlD
Ziprasidone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00044	0.00427	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000437	0.00424	CcSEcCtD
Ziprasidone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000425	0.00412	CcSEcCtD
Ziprasidone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000422	0.0041	CcSEcCtD
Ziprasidone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000422	0.0041	CcSEcCtD
Ziprasidone—HTR2A—renal system—nephrolithiasis	0.000406	0.0109	CbGeAlD
Ziprasidone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000394	0.00382	CcSEcCtD
Ziprasidone—HTR2A—kidney—nephrolithiasis	0.000393	0.0105	CbGeAlD
Ziprasidone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000383	0.00372	CcSEcCtD
Ziprasidone—CYP3A4—renal system—nephrolithiasis	0.000376	0.0101	CbGeAlD
Ziprasidone—CYP2D6—renal system—nephrolithiasis	0.00037	0.00992	CbGeAlD
Ziprasidone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000366	0.00355	CcSEcCtD
Ziprasidone—CYP3A4—kidney—nephrolithiasis	0.000363	0.00974	CbGeAlD
Ziprasidone—CYP2D6—kidney—nephrolithiasis	0.000358	0.00959	CbGeAlD
Ziprasidone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000353	0.00343	CcSEcCtD
Ziprasidone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00034	0.0033	CcSEcCtD
Ziprasidone—Rash—Hydrochlorothiazide—nephrolithiasis	0.000337	0.00327	CcSEcCtD
Ziprasidone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000337	0.00327	CcSEcCtD
Ziprasidone—Headache—Hydrochlorothiazide—nephrolithiasis	0.000335	0.00325	CcSEcCtD
Ziprasidone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000317	0.00308	CcSEcCtD
Ziprasidone—HTR6—Signaling by GPCR—PTH—nephrolithiasis	6.42e-05	0.000512	CbGpPWpGaD
Ziprasidone—HTR7—Signaling by GPCR—PTH—nephrolithiasis	6.41e-05	0.000512	CbGpPWpGaD
Ziprasidone—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	6.39e-05	0.00051	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	6.39e-05	0.00051	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	6.37e-05	0.000509	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—PTH—nephrolithiasis	6.37e-05	0.000509	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	6.35e-05	0.000507	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	6.34e-05	0.000506	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	6.33e-05	0.000505	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	6.31e-05	0.000504	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	6.29e-05	0.000502	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	6.27e-05	0.0005	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	6.25e-05	0.000499	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	6.25e-05	0.000499	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—PTH—nephrolithiasis	6.24e-05	0.000498	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	6.22e-05	0.000497	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	6.21e-05	0.000496	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	6.2e-05	0.000495	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	6.18e-05	0.000493	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	6.16e-05	0.000491	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—PTH—nephrolithiasis	6.14e-05	0.00049	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	6.1e-05	0.000487	CbGpPWpGaD
Ziprasidone—DRD1—GPCR downstream signaling—PTH—nephrolithiasis	6.09e-05	0.000486	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—RGS14—nephrolithiasis	6.08e-05	0.000485	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	6.08e-05	0.000485	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—CHRM3—nephrolithiasis	6.07e-05	0.000485	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—PTH—nephrolithiasis	6.06e-05	0.000483	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—CHRM3—nephrolithiasis	6.04e-05	0.000482	CbGpPWpGaD
Ziprasidone—DRD3—GPCR downstream signaling—PTH—nephrolithiasis	6.01e-05	0.000479	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	5.99e-05	0.000478	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—CHRM3—nephrolithiasis	5.96e-05	0.000476	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	5.93e-05	0.000473	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—GRHPR—nephrolithiasis	5.91e-05	0.000472	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	5.81e-05	0.000464	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	5.8e-05	0.000463	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—AGXT—nephrolithiasis	5.74e-05	0.000458	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.74e-05	0.000458	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—DGKH—nephrolithiasis	5.74e-05	0.000458	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.73e-05	0.000457	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—DGKH—nephrolithiasis	5.73e-05	0.000457	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	5.72e-05	0.000457	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	5.69e-05	0.000454	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.69e-05	0.000454	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—DGKH—nephrolithiasis	5.69e-05	0.000454	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	5.68e-05	0.000453	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—APRT—nephrolithiasis	5.68e-05	0.000453	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	5.65e-05	0.000451	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.57e-05	0.000445	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—DGKH—nephrolithiasis	5.57e-05	0.000445	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—PTH—nephrolithiasis	5.55e-05	0.000443	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—CHRM3—nephrolithiasis	5.54e-05	0.000442	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—PTH—nephrolithiasis	5.53e-05	0.000441	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—RGS14—nephrolithiasis	5.52e-05	0.00044	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—SLC26A1—nephrolithiasis	5.51e-05	0.00044	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—APRT—nephrolithiasis	5.51e-05	0.00044	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.49e-05	0.000438	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—DGKH—nephrolithiasis	5.49e-05	0.000438	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—PTH—nephrolithiasis	5.45e-05	0.000435	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	5.45e-05	0.000435	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	5.43e-05	0.000433	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	5.42e-05	0.000433	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—RGS14—nephrolithiasis	5.42e-05	0.000432	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—GRHPR—nephrolithiasis	5.42e-05	0.000432	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.41e-05	0.000432	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—DGKH—nephrolithiasis	5.41e-05	0.000432	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	5.4e-05	0.000431	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	5.39e-05	0.00043	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	5.38e-05	0.00043	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—CHRM3—nephrolithiasis	5.37e-05	0.000429	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	5.33e-05	0.000426	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	5.32e-05	0.000424	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—AGXT—nephrolithiasis	5.27e-05	0.00042	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	5.23e-05	0.000418	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	5.21e-05	0.000416	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	5.2e-05	0.000415	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.18e-05	0.000414	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	5.18e-05	0.000414	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	5.17e-05	0.000413	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—PTH—nephrolithiasis	5.07e-05	0.000404	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—CHRM3—nephrolithiasis	5.03e-05	0.000401	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	5.03e-05	0.000401	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	4.99e-05	0.000398	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	4.95e-05	0.000395	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	4.94e-05	0.000395	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	4.94e-05	0.000394	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.94e-05	0.000394	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—DGKH—nephrolithiasis	4.94e-05	0.000394	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	4.93e-05	0.000394	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	4.92e-05	0.000393	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	4.92e-05	0.000392	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—PTH—nephrolithiasis	4.91e-05	0.000392	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—SLC26A1—nephrolithiasis	4.88e-05	0.000389	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—APRT—nephrolithiasis	4.88e-05	0.000389	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.87e-05	0.000389	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—DGKH—nephrolithiasis	4.87e-05	0.000389	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	4.85e-05	0.000387	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	4.84e-05	0.000386	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—AGXT—nephrolithiasis	4.83e-05	0.000385	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	4.75e-05	0.000379	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	4.73e-05	0.000377	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—PTH—nephrolithiasis	4.6e-05	0.000367	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	4.6e-05	0.000367	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	4.56e-05	0.000364	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	4.53e-05	0.000361	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	4.52e-05	0.000361	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	4.51e-05	0.00036	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	4.5e-05	0.000359	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	4.5e-05	0.000359	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	4.49e-05	0.000358	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	4.48e-05	0.000358	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	4.48e-05	0.000358	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—APRT—nephrolithiasis	4.48e-05	0.000357	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	4.48e-05	0.000357	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	4.47e-05	0.000356	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	4.44e-05	0.000354	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	4.43e-05	0.000353	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	4.41e-05	0.000352	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.4e-05	0.000351	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	4.4e-05	0.000351	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	4.4e-05	0.000351	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.25e-05	0.000339	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	4.25e-05	0.000339	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.22e-05	0.000337	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	4.22e-05	0.000337	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—PTH—nephrolithiasis	4.17e-05	0.000333	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—CHRM3—nephrolithiasis	4.15e-05	0.000331	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—CHRM3—nephrolithiasis	4.14e-05	0.000331	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—CHRM3—nephrolithiasis	4.12e-05	0.000328	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	4.11e-05	0.000328	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—DGKH—nephrolithiasis	4.11e-05	0.000328	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.11e-05	0.000328	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	4.11e-05	0.000328	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—APRT—nephrolithiasis	4.1e-05	0.000328	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	4.1e-05	0.000328	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—PTH—nephrolithiasis	4.1e-05	0.000327	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	4.08e-05	0.000326	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	4.08e-05	0.000326	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	4.07e-05	0.000325	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—AQP1—nephrolithiasis	4.05e-05	0.000323	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.04e-05	0.000323	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	4.04e-05	0.000323	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	4.03e-05	0.000322	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—CHRM3—nephrolithiasis	4.03e-05	0.000322	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	4.02e-05	0.000321	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—CHRM3—nephrolithiasis	3.97e-05	0.000317	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—AQP1—nephrolithiasis	3.93e-05	0.000314	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—CHRM3—nephrolithiasis	3.91e-05	0.000312	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—GRHPR—nephrolithiasis	3.85e-05	0.000307	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—PTH—nephrolithiasis	3.79e-05	0.000303	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—PTH—nephrolithiasis	3.79e-05	0.000302	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—PTH—nephrolithiasis	3.76e-05	0.0003	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	3.75e-05	0.000299	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	3.74e-05	0.000298	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—DGKH—nephrolithiasis	3.73e-05	0.000298	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.73e-05	0.000298	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—PTH—nephrolithiasis	3.69e-05	0.000294	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.67e-05	0.000293	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	3.67e-05	0.000293	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.66e-05	0.000292	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—DGKH—nephrolithiasis	3.66e-05	0.000292	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—CHRM3—nephrolithiasis	3.66e-05	0.000292	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.65e-05	0.000291	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	3.65e-05	0.000291	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	3.64e-05	0.00029	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.64e-05	0.00029	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—PTH—nephrolithiasis	3.63e-05	0.000289	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.6e-05	0.000287	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	3.6e-05	0.000287	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.59e-05	0.000287	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	3.59e-05	0.000287	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—PTH—nephrolithiasis	3.58e-05	0.000286	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CHRM3—nephrolithiasis	3.57e-05	0.000285	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—CHRM3—nephrolithiasis	3.55e-05	0.000284	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CHRM3—nephrolithiasis	3.52e-05	0.000281	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—AQP1—nephrolithiasis	3.48e-05	0.000278	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—AGXT—nephrolithiasis	3.43e-05	0.000274	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—PTH—nephrolithiasis	3.43e-05	0.000273	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	3.34e-05	0.000266	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.34e-05	0.000266	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—PTH—nephrolithiasis	3.27e-05	0.000261	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GRHPR—nephrolithiasis	3.26e-05	0.00026	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—PTH—nephrolithiasis	3.22e-05	0.000257	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—AQP1—nephrolithiasis	3.19e-05	0.000255	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	3.18e-05	0.000254	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	3.07e-05	0.000245	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	3.05e-05	0.000244	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CHRM3—nephrolithiasis	2.97e-05	0.000237	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—AQP1—nephrolithiasis	2.92e-05	0.000233	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	2.92e-05	0.000233	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—APRT—nephrolithiasis	2.92e-05	0.000233	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	2.92e-05	0.000233	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	2.91e-05	0.000232	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AGXT—nephrolithiasis	2.91e-05	0.000232	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—CHRM3—nephrolithiasis	2.89e-05	0.00023	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—PTH—nephrolithiasis	2.81e-05	0.000224	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—PTH—nephrolithiasis	2.79e-05	0.000223	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—SPP1—nephrolithiasis	2.79e-05	0.000222	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—PTH—nephrolithiasis	2.72e-05	0.000217	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	2.7e-05	0.000215	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	2.67e-05	0.000213	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	2.65e-05	0.000212	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	2.65e-05	0.000211	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—CHRM3—nephrolithiasis	2.64e-05	0.000211	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	2.64e-05	0.000211	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	2.6e-05	0.000208	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	2.6e-05	0.000207	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GRHPR—nephrolithiasis	2.52e-05	0.000201	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	2.47e-05	0.000197	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APRT—nephrolithiasis	2.47e-05	0.000197	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—SPP1—nephrolithiasis	2.47e-05	0.000197	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—PTH—nephrolithiasis	2.47e-05	0.000197	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—PTH—nephrolithiasis	2.43e-05	0.000194	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—PTH—nephrolithiasis	2.42e-05	0.000193	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	2.41e-05	0.000193	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—PTH—nephrolithiasis	2.41e-05	0.000193	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—PTH—nephrolithiasis	2.41e-05	0.000192	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—PTH—nephrolithiasis	2.38e-05	0.00019	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	2.38e-05	0.00019	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AGXT—nephrolithiasis	2.24e-05	0.000179	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	2.21e-05	0.000176	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—AQP1—nephrolithiasis	2.08e-05	0.000166	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APRT—nephrolithiasis	1.91e-05	0.000152	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	1.91e-05	0.000152	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—SPP1—nephrolithiasis	1.9e-05	0.000152	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—SPP1—nephrolithiasis	1.9e-05	0.000152	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—SPP1—nephrolithiasis	1.89e-05	0.000151	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CHRM3—nephrolithiasis	1.88e-05	0.00015	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—SPP1—nephrolithiasis	1.85e-05	0.000148	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—SPP1—nephrolithiasis	1.82e-05	0.000145	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—SPP1—nephrolithiasis	1.8e-05	0.000143	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AQP1—nephrolithiasis	1.76e-05	0.000141	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	1.72e-05	0.000137	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—SPP1—nephrolithiasis	1.64e-05	0.000131	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—SPP1—nephrolithiasis	1.62e-05	0.000129	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CHRM3—nephrolithiasis	1.59e-05	0.000127	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	1.46e-05	0.000117	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	1.41e-05	0.000112	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	1.4e-05	0.000112	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—SPP1—nephrolithiasis	1.36e-05	0.000109	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AQP1—nephrolithiasis	1.36e-05	0.000108	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	1.34e-05	0.000107	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—SPP1—nephrolithiasis	1.24e-05	9.88e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CHRM3—nephrolithiasis	1.23e-05	9.81e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	1.22e-05	9.72e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—SPP1—nephrolithiasis	1.22e-05	9.7e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	1.21e-05	9.67e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	1.21e-05	9.64e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	1.2e-05	9.54e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	1.19e-05	9.52e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	1.11e-05	8.84e-05	CbGpPWpGaD
